| 23 | N | N | N | Ethinamate
 | CA4: carbonic anhydrase IV (EC:4.2.1.1) | 0.10000 | Sezolamide hydrochloride
 | 0.23167 | CA2: carbonic anhydrase II (EC:4.2.1.1) |
| 24 | N | N | N | Deferoxamine
 | CYP39A1 | 0.14000 | Tolbutamide
 | 0.15698 | CYP8B1: cytochrome P450, family 8, subfamily B, polypeptide 1 (EC:1.14.13.95) |
| 33 | N | N | N | Voglibose
 | AMY2A: amylase, alpha 2A (pancreatic) (EC:3.2.1.1) | 0.45454 | Miglitol
 | 0.012625 | GANC: glucosidase, alpha; neutral C (EC:3.2.1.20) |
| 37 | N | N | N | Cyclosporine
 | PPIL4: peptidylprolyl isomerase (cyclophilin)-like 4 (EC:5.2.1.8) | 0.22222 | Tacrolimus
 | 0.030219 | PPP1R1B: protein phosphatase 1, regulatory (inhibitor) subunit 1B (EC:3.1.3.16) |
| 39 | N | N | N | Deferoxamine
| COQ6 | 0.14000 | Tolbutamide
| 0.023550 | PRDX3: peroxiredoxin 3 (EC:1.11.1.15) |
| 43 | N | N | N | Celgosivir hydrochloride
 | AMY2A: amylase, alpha 2A (pancreatic) (EC:3.2.1.1) | 0.43478 | Miglitol
| 0.012625 | GANC: glucosidase, alpha; neutral C (EC:3.2.1.20) |
| 44 | N | N | N | Cyclosporine
| PPIL3: peptidylprolyl isomerase (cyclophilin)-like 3 (EC:5.2.1.8) | 0.22222 | Tacrolimus
| 0.063026 | DUSP15: dual specificity phosphatase 15 (EC:3.1.3.16 3.1.3.48) |
| 53 | N | N | N | Cyclosporine
| PPID: peptidylprolyl isomerase D (EC:5.2.1.8) | 0.22222 | Tacrolimus
| 0.053636 | PPP5C: protein phosphatase 5, catalytic subunit (EC:3.1.3.16) |
| 63 | N | N | N | Cyclosporine
| PPIL1: peptidylprolyl isomerase (cyclophilin)-like 1 (EC:5.2.1.8) | 0.22222 | Tacrolimus
| 0.038764 | DUSP13: dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48) |
| 69 | N | N | N | Cyclosporine
| : peptidyl-prolyl cis-trans isomerase A-like | 0.22222 | Tacrolimus
| 0.041770 | DUSP15: dual specificity phosphatase 15 (EC:3.1.3.16 3.1.3.48) |
| 70 | Y | N | N | Cyclosporine
| PPIB: peptidylprolyl isomerase B (cyclophilin B) (EC:5.2.1.8) | 0.22222 | Tacrolimus
| 0.036951 | DUSP21: dual specificity phosphatase 21 (EC:3.1.3.16 3.1.3.48) |
| 76 | N | N | N | Milrinone
 | ATM: ataxia telangiectasia mutated (EC:2.7.11.1) | 0.30435 | Caffeine
 | 0.012516 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 90 | N | N | N | Propylthiouracil
 | FMO1 | 0.38461 | Methimazole
 | 0.020430 | DIO2: deiodinase, iodothyronine, type II (EC:1.97.1.10) |
| 93 | N | N | N | Aminocaproic acid
 | PRCP: prolylcarboxypeptidase (angiotensinase C) (EC:3.4.16.2) | 0 | Isoflurophate
 | 0.15192 | PRSS16: protease, serine, 16 (thymus) |
| 105 | Y | Y | N | Cyclosporine
| PPIA: peptidylprolyl isomerase A (cyclophilin A) (EC:5.2.1.8) | 0.22222 | Tacrolimus
| 0.040823 | DUSP13: dual specificity phosphatase 13 (EC:3.1.3.16 3.1.3.48) |
| 108 | N | N | N | Milrinone
| NT5C: 5', 3'-nucleotidase, cytosolic (EC:3.1.3.5) | 0.24138 | Pentoxifylline
 | 0.037756 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 109 | N | N | N | Milrinone
| IMPA1: inositol(myo)-1(or 4)-monophosphatase 1 (EC:3.1.3.25) | 0.24138 | Pentoxifylline
| 0.038864 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 110 | N | N | N | Milrinone
| NT5C3: 5'-nucleotidase, cytosolic III (EC:3.1.3.5) | 0.24138 | Pentoxifylline
| 0.033948 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 111 | N | N | N | Aminocaproic acid
| TPP1: tripeptidyl peptidase I (EC:3.4.14.9) | 0 | Isoflurophate
| 0.030918 | SPCS1: signal peptidase complex subunit 1 homolog (S. cerevisiae) (EC:3.4.-.-) |
| 112 | N | N | N | Milrinone
| RDH14: retinol dehydrogenase 14 (all-trans/9-cis/11-cis) (EC:1.1.1.-) | 0.24138 | Pentoxifylline
| 0.047768 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 113 | N | N | N | Milrinone
| NT5C1A: 5'-nucleotidase, cytosolic IA (EC:3.1.3.5) | 0.24138 | Pentoxifylline
| 0.031796 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 115 | N | N | N | Aminocaproic acid
| CTSA: cathepsin A (EC:3.4.16.5) | 0 | Isoflurophate
| 0.027247 | PRTN3: proteinase 3 (EC:3.4.21.76) |
| 118 | N | N | N | Milrinone
| NT5E: 5'-nucleotidase, ecto (CD73) (EC:3.1.3.5) | 0.24138 | Pentoxifylline
| 0.023490 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 120 | N | N | N | Aminocaproic acid
| APEH: N-acylaminoacyl-peptide hydrolase (EC:3.4.19.1) | 0 | Isoflurophate
| 0.038792 | SPCS1: signal peptidase complex subunit 1 homolog (S. cerevisiae) (EC:3.4.-.-) |
| 128 | N | N | N | Aminocaproic acid
| DPP4: dipeptidyl-peptidase 4 (EC:3.4.14.5) | 0 | Isoflurophate
| 0.025117 | KLK7: kallikrein-related peptidase 7 (EC:3.4.21.117) |
| 148 | N | N | N | Propylthiouracil
| FMO3: flavin containing monooxygenase 3 (EC:1.14.13.8) | 0.38461 | Methimazole
| 0.025611 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 155 | N | N | N | Ketotifen fumarate
 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.45714 | Zaltoprofen
 | 0.019709 | ALOX15B: arachidonate 15-lipoxygenase, type B (EC:1.13.11.33) |
| 161 | N | N | N | Aminocaproic acid
| DPP8: dipeptidyl-peptidase 8 (EC:3.4.14.5) | 0 | Isoflurophate
| 0.028464 | KLK7: kallikrein-related peptidase 7 (EC:3.4.21.117) |
| 165 | N | N | N | Aminocaproic acid
| DPP9: dipeptidyl-peptidase 9 (EC:3.4.14.5) | 0 | Isoflurophate
| 0.029891 | PREP: prolyl endopeptidase (EC:3.4.21.26) |
| 167 | N | N | N | Aminocaproic acid
| PON1: paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) | 0 | Isoflurophate
| 0.040345 | SPCS1: signal peptidase complex subunit 1 homolog (S. cerevisiae) (EC:3.4.-.-) |
| 168 | N | N | N | Aminocaproic acid
| PON2 | 0 | Isoflurophate
| 0.033017 | TPSD1: tryptase delta 1 (EC:3.4.21.59) |
| 169 | N | N | N | Benzthiazide
 | ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.48387 | Methyclothiazide
 | 0.013918 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 172 | N | N | N | Milrinone
| NT5C2: 5'-nucleotidase, cytosolic II (EC:3.1.3.5) | 0.24138 | Pentoxifylline
| 0.036376 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 179 | N | N | N | Orlistat
 | PLA1A: phospholipase A1 member A (EC:3.1.1.-) | 0.20000 | Capecitabine
 | 0.20191 | LIPC: lipase, hepatic (EC:3.1.1.3) |
| 188 | N | N | N | Aminocaproic acid
| ESD: esterase D (EC:3.1.2.12) | 0.13333 | Capecitabine
| 0.043535 | ? |
| 190 | N | N | N | Ketotifen fumarate
| LALBA: lactalbumin, alpha- (EC:2.4.1.22) | 0.32432 | Ketoprofen
 | 0.035630 | PDE7B: phosphodiesterase 7B (EC:3.1.4.17) |
| 208 | N | N | N | Metrifonate
 | ATP5D | 0.35714 | Halothane
 | 0.027573 | ACHE: acetylcholinesterase (EC:3.1.1.7) |
| 210 | N | N | N | Hydroxocobalamin
 | MAT1A: methionine adenosyltransferase I, alpha (EC:2.5.1.6) | 0.041237 | Racemethionine
 | 0.020944 | MMAB: methylmalonic aciduria (cobalamin deficiency) cblB type (EC:2.5.1.17) |
| 213 | N | N | N | Propylthiouracil
| PRDX1: peroxiredoxin 1 (EC:1.11.1.15) | 0.22222 | Acetaminophen
 | 0.044594 | DIO3: deiodinase, iodothyronine, type III (EC:1.97.1.11) |
| 214 | N | N | N | Hydroxocobalamin
| MSRA: methionine sulfoxide reductase A (EC:1.8.4.11) | 0.041237 | Racemethionine
| 0.024392 | MMAB: methylmalonic aciduria (cobalamin deficiency) cblB type (EC:2.5.1.17) |
| 216 | Y | Y | N | Fluconazole
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.40625 | Liarozole hydrochloride
 | 0.14915 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 220 | N | N | N | Propylthiouracil
| PRDX3: peroxiredoxin 3 (EC:1.11.1.15) | 0.22222 | Acetaminophen
| 0.035109 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 223 | N | N | N | Propylthiouracil
| PRDX4: peroxiredoxin 4 (EC:1.11.1.15) | 0.22222 | Acetaminophen
| 0.031414 | DIO3: deiodinase, iodothyronine, type III (EC:1.97.1.11) |
| 225 | N | Y | N | Phenytoin
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.44444 | Diazepam
 | 0.14915 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 226 | N | N | N | Metrifonate
| ATP2C1: ATPase, Ca++ transporting, type 2C, member 1 (EC:3.6.3.8) | 0.35714 | Halothane
| 0.011472 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 229 | N | N | N | Racemethionine
| MUT: methylmalonyl CoA mutase (EC:5.4.99.2) | 0.041237 | Hydroxocobalamin
| 0.017685 | MSRA: methionine sulfoxide reductase A (EC:1.8.4.11) |
| 230 | N | N | N | Exemestane
 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.48485 | Fluorometholone
 | 0.014633 | CYP19A1: cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
| 234 | N | N | N | Racemethionine
| MMAB: methylmalonic aciduria (cobalamin deficiency) cblB type (EC:2.5.1.17) | 0.041237 | Hydroxocobalamin
| 0.024392 | MSRA: methionine sulfoxide reductase A (EC:1.8.4.11) |
| 236 | N | N | N | Salicylic acid
 | LALBA: lactalbumin, alpha- (EC:2.4.1.22) | 0.38889 | Ibuprofen
 | 0.034331 | LPO: lactoperoxidase (EC:1.11.1.7) |
| 239 | N | N | N | Diethylstilbestrol
 | SULT1A2: sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) | 0.34783 | Acetaminophen
| 0.034942 | GPX5 |
| 246 | N | N | N | Astemizole
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.46154 | Clozapine
 | 0.24342 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 253 | N | N | N | Testolactone
 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.48485 | Fluorometholone
| 0.014633 | CYP19A1: cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
| 257 | N | N | N | Ketotifen fumarate
| PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.45714 | Zaltoprofen
| 0.016976 | LTA4H |
| 258 | N | N | N | Acetaminophen
| GPX4: glutathione peroxidase 4 (phospholipid hydroperoxidase) (EC:1.11.1.12) | 0.34783 | Diethylstilbestrol
| 0.046704 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 259 | N | Y | N | Diazoxide
 | ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.36000 | Methyclothiazide
| 0.013918 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 267 | N | N | N | Propylthiouracil
| PRDX5: peroxiredoxin 5 (EC:1.11.1.15) | 0.22222 | Acetaminophen
| 0.036495 | DIO2: deiodinase, iodothyronine, type II (EC:1.97.1.10) |
| 273 | N | N | N | Acetaminophen
| GPX7: glutathione peroxidase 7 (EC:1.11.1.9) | 0.34783 | Diethylstilbestrol
| 0.036838 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
| 278 | N | Y | N | Terfenadine
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.42500 | Trimipramine
 | 0.24342 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 279 | Y | Y | N | Nicotine
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.39130 | Mirtazapine
 | 0.24056 | CYP2A13: cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) |
| 284 | N | N | N | Nilutamide
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.37500 | Risarestat
 | 0.014469 | POR: P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
| 285 | N | Y | N | Cisapride
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.37500 | Clozapine
| 0.24342 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 287 | N | N | N | Ketotifen fumarate
| PDE11A: phosphodiesterase 11A (EC:3.1.4.35 3.1.4.17) | 0.37209 | Vesnarinone
 | 0.14623 | PDE7A: phosphodiesterase 7A (EC:3.1.4.17) |
| 288 | N | N | N | Aripiprazole
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.47222 | Clozapine
| 0.24342 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 293 | N | Y | N | Miconazole nitrate
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.48571 | Liarozole hydrochloride
| 0.14915 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 302 | N | N | N | Salicylic acid
| DIO3: deiodinase, iodothyronine, type III (EC:1.97.1.11) | 0.31250 | Acetaminophen
| 0.025577 | ALOX12: arachidonate 12-lipoxygenase (EC:1.13.11.31) |
| 305 | N | N | N | Ketotifen fumarate
| IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | 0.34146 | Sulindac
 | 0.016539 | PDE7A: phosphodiesterase 7A (EC:3.1.4.17) |
| 309 | N | N | N | Salicylic acid
| DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) | 0.31250 | Acetaminophen
| 0.022411 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
| 311 | N | N | N | Salicylic acid
| DIO2: deiodinase, iodothyronine, type II (EC:1.97.1.10) | 0.31250 | Acetaminophen
| 0.022216 | ALOX12: arachidonate 12-lipoxygenase (EC:1.13.11.31) |
| 319 | N | N | N | Efegatran sulfate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.46512 | Alacepril
 | 0.010996 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) |
| 320 | N | N | N | Naproxen
 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | 0.44828 | Sulindac
| 0.014552 | ALOX15B: arachidonate 15-lipoxygenase, type B (EC:1.13.11.33) |
| 323 | N | N | N | Diethylstilbestrol
| WARS: tryptophanyl-tRNA synthetase (EC:6.1.1.2) | 0.19231 | Propylthiouracil
| 0.027023 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 327 | N | N | N | Acetaminophen
| WARS: tryptophanyl-tRNA synthetase (EC:6.1.1.2) | 0.22222 | Propylthiouracil
| 0.027023 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 328 | N | N | N | Propofol
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.44444 | Edrophonium chloride
 | 0.012915 | ACOX1: acyl-CoA oxidase 1, palmitoyl (EC:1.3.3.6) |
| 332 | N | N | N | Disulfiram
 | ALDH6A1: aldehyde dehydrogenase 6 family, member A1 (EC:1.2.1.27 1.2.1.18) | 0.090909 | Valine
 | 0.22923 | ALDH9A1: aldehyde dehydrogenase 9 family, member A1 (EC:1.2.1.3 1.2.1.19 1.2.1.47) |
| 334 | N | N | N | Acetaminophen
| GPX2: glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) | 0.34783 | Diethylstilbestrol
| 0.035543 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 335 | N | N | N | Acetaminophen
| GPX3: glutathione peroxidase 3 (plasma) (EC:1.11.1.9) | 0.34783 | Diethylstilbestrol
| 0.038088 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 338 | N | N | N | Levetiracetam
 | CA4: carbonic anhydrase IV (EC:4.2.1.1) | 0.17857 | Sezolamide hydrochloride
| 0.19740 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 349 | N | Y | N | Bisoprolol
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.34959 | Verapamil
 | 0.13075 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 350 | N | N | N | Acetaminophen
| GPX5 | 0.34783 | Diethylstilbestrol
| 0.035631 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 355 | N | N | N | Salicylic acid
| IKBKE: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10) | 0.31034 | Sulfasalazine
 | 0.10355 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
| 358 | N | N | N | Glutathione
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.39474 | Zofenoprilat arginine
 | 0.013195 | GSTP1: glutathione S-transferase pi 1 (EC:2.5.1.18) |
| 365 | N | Y | N | Imatinib mesilate
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.38750 | Terfenadine
| 0.025570 | ERBB3: v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1) |
| 368 | N | N | N | Diethylstilbestrol
| CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.44444 | Diphenhydramine
 | 0.029507 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 369 | N | N | N | Glimepiride
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.39130 | Ramipril
 | 0.011541 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 377 | N | N | N | Sulfasalazine
| LALBA: lactalbumin, alpha- (EC:2.4.1.22) | 0.34286 | Ketoprofen
| 0.032575 | ALOX15B: arachidonate 15-lipoxygenase, type B (EC:1.13.11.33) |
| 378 | N | N | N | Deferoxamine
| SULT1A2: sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) | 0.063830 | Acetaminophen
| 0.028580 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 382 | N | N | N | Acetaminophen
| GPX1: glutathione peroxidase 1 (EC:1.11.1.9) | 0.34783 | Diethylstilbestrol
| 0.037431 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 395 | N | N | N | Riboflavin
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.45161 | Ganciclovir
 | 0.028932 | BLVRB: biliverdin reductase B (flavin reductase (NADPH)) (EC:1.3.1.24 1.5.1.30) |
| 396 | N | N | N | Alvocidib hydrochloride
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.44444 | Clozapine
| 0.021886 | CDK3 |
| 400 | N | N | N | Imatinib mesilate
| CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.38776 | Mesoridazine
 | 0.024668 | MAP2K3: mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
| 414 | N | N | N | Acetaminophen
| CYC1: cytochrome c-1 | 0.063830 | Deferoxamine
| 0.034093 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 415 | N | N | N | Diethylstilbestrol
| PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.45161 | Mofezolac
 | 0.046083 | LPO: lactoperoxidase (EC:1.11.1.7) |
| 419 | N | N | N | Phytonadione
 | DHRS4: dehydrogenase/reductase (SDR family) member 4 (EC:1.1.1.184) | 0.35294 | Menadione
 | 0.015477 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 430 | N | N | N | Phytonadione
| PROC: protein C (inactivator of coagulation factors Va and VIIIa) (EC:3.4.21.69) | 0.35294 | Menadione
| 0.012858 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 444 | N | N | N | Milrinone
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.36000 | Fadrozole hydrochloride
 | 0.029363 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 446 | N | N | N | Acetaminophen
| FECH: ferrochelatase (EC:4.99.1.1) | 0.063830 | Deferoxamine
| 0.028826 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 447 | N | Y | N | Acetaminophen
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.38095 | Tolbutamide
| 0.13322 | CYP2E1: cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.14.1) |
| 454 | N | N | N | Bisoprolol
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.33333 | Phenacetin
 | 0.24342 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 455 | N | N | N | Oxiconazole nitrate
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.21053 | Acyclovir
 | 0.015455 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 457 | N | N | N | Diethylstilbestrol
| PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.45161 | Mofezolac
| 0.043421 | LPO: lactoperoxidase (EC:1.11.1.7) |
| 458 | N | N | N | Ketoprofen
| IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | 0.46667 | Sulindac
| 0.021136 | LALBA: lactalbumin, alpha- (EC:2.4.1.22) |
| 464 | N | N | N | Dyphylline
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.44000 | Ganciclovir
| 0.029970 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 466 | N | N | N | Eflornithine hydrochloride
 | ATP5D | 0.26316 | Enflurane
 | 0.026235 | ODC1: ornithine decarboxylase 1 (EC:4.1.1.17) |
| 467 | N | N | N | Terlakiren
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.40678 | Fosinopril sodium
 | 0.0094680 | REN: renin (EC:3.4.23.15) |
| 468 | N | Y | N | Zaleplon
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.42857 | Metyrapone
 | 0.013301 | ACOX1: acyl-CoA oxidase 1, palmitoyl (EC:1.3.3.6) |
| 470 | N | N | N | Eflornithine hydrochloride
| ATP2C1: ATPase, Ca++ transporting, type 2C, member 1 (EC:3.6.3.8) | 0.26316 | Enflurane
| 0.013503 | ODC1: ornithine decarboxylase 1 (EC:4.1.1.17) |
| 473 | N | N | N | Gemcitabine
 | POLA1: polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7) | 0.40000 | Fludarabine phosphate
 | 0.017727 | CMPK1: cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (EC:2.7.4.14) |
| 475 | N | N | N | Biotin
 | BCKDK | 0.19048 | Isoleucine
 | 0.021419 | PCCB: propionyl CoA carboxylase, beta polypeptide (EC:6.4.1.3) |
| 485 | N | N | N | Phytonadione
| F2: coagulation factor II (thrombin) (EC:3.4.21.5) | 0.35294 | Menadione
| 0.010540 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 486 | N | Y | N | Nicotine
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.39130 | Mirtazapine
| 0.14011 | CYP2A7: cytochrome P450, family 2, subfamily A, polypeptide 7 (EC:1.14.14.1) |
| 489 | N | N | N | Cilastatin sodium
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.34884 | Zofenoprilat arginine
| 0.015368 | DPEP1: dipeptidase 1 (renal) (EC:3.4.13.19) |
| 490 | N | N | N | Diethylstilbestrol
| CYC1: cytochrome c-1 | 0.035088 | Deferoxamine
| 0.034093 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 491 | N | N | N | Acetaminophen
| PIK3CG: phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153) | 0.063830 | Deferoxamine
| 0.015683 | PRDX4: peroxiredoxin 4 (EC:1.11.1.15) |
| 496 | N | N | N | Trilostane
 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.40000 | Medrysone
 | 0.013333 | HSD3B1: hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1) |
| 499 | N | N | N | Salicylic acid
| NAT2: N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5) | 0.31034 | Sulfasalazine
| 0.022765 | ALOX15B: arachidonate 15-lipoxygenase, type B (EC:1.13.11.33) |
| 501 | N | N | N | Aminocaproic acid
| F2: coagulation factor II (thrombin) (EC:3.4.21.5) | 0.13953 | Napsagatran
 | 0.19139 | F10: coagulation factor X (EC:3.4.21.6) |
| 503 | N | N | N | Diethylstilbestrol
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.43750 | Haloperidol
 | 0.025357 | GPX7: glutathione peroxidase 7 (EC:1.11.1.9) |
| 505 | N | N | N | Lopinavir
 | REN: renin (EC:3.4.23.15) | 0.40941 | Enalkiren
 | 0.020542 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 507 | N | N | N | Bentiromide
 | ELANE: elastase, neutrophil expressed (EC:3.4.21.37) | 0.42857 | Sivelestat
 | 0.24292 | CTRC: chymotrypsin C (caldecrin) (EC:3.4.21.2) |
| 508 | N | N | N | Imatinib mesilate
| PRKAA1: protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1) | 0.12069 | Adenosine phosphate
 | 0.10391 | MAP2K2: mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
| 509 | N | N | N | Topiramate
 | ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.16667 | Digoxin
 | 0.013190 | CA2: carbonic anhydrase II (EC:4.2.1.1) |
| 515 | N | N | N | Alvocidib hydrochloride
| CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.44444 | Clozapine
| 0.032780 | CDK5: cyclin-dependent kinase 5 (EC:2.7.11.22) |
| 518 | N | N | N | Diethylstilbestrol
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.40000 | Letrozole
 | 0.036838 | GPX7: glutathione peroxidase 7 (EC:1.11.1.9) |
| 523 | N | N | N | Diethylstilbestrol
| FECH: ferrochelatase (EC:4.99.1.1) | 0.035088 | Deferoxamine
| 0.043148 | GPX7: glutathione peroxidase 7 (EC:1.11.1.9) |
| 525 | N | N | N | Aminocaproic acid
| ENPP1: ectonucleotide pyrophosphatase/phosphodiesterase 1 (EC:3.1.4.1 3.6.1.9) | 0.16000 | Pentoxifylline
| 0.026382 | KLK1: kallikrein 1 (EC:3.4.21.35) |
| 526 | N | N | N | Diethylstilbestrol
| PIK3CG: phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153) | 0.035088 | Deferoxamine
| 0.022324 | GPX1: glutathione peroxidase 1 (EC:1.11.1.9) |
| 527 | N | N | N | Ketorolac tromethamine
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.42500 | Ceronapril
 | 0.013176 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 535 | Y | Y | N | Zileuton
 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.47826 | Tiaprofenic acid
 | 0.012760 | ALOX5: arachidonate 5-lipoxygenase (EC:1.13.11.34) |
| 538 | N | N | N | Pyrimethamine
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.40000 | Chlorzoxazone
 | 0.025376 | DHFR: dihydrofolate reductase (EC:1.5.1.3) |
| 544 | N | N | N | Flurbiprofen axetil
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.41379 | Neostigmine bromide
 | 0.014743 | PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 546 | N | N | N | Rosiglitazone maleate
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.32500 | Diazepam
| 0.14990 | CYP2C8: cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
| 551 | N | N | N | Phytonadione
| VKORC1: vitamin K epoxide reductase complex, subunit 1 (EC:1.1.4.1) | 0.35294 | Menadione
| 0.025117 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 552 | N | N | N | Donepezil hydrochloride
 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.48780 | Cisapride
| 0.017115 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 553 | N | N | N | Nilutamide
| NQO1: NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) | 0.15000 | Mitomycin
 | 0.018752 | POR: P450 (cytochrome) oxidoreductase (EC:1.6.2.4) |
| 554 | N | N | N | Rosiglitazone maleate
| AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.37500 | Risarestat
| 0.019157 | CYP2C8: cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
| 555 | Y | Y | N | Chlorzoxazone
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.34783 | Diazepam
| 0.14011 | CYP2A7: cytochrome P450, family 2, subfamily A, polypeptide 7 (EC:1.14.14.1) |
| 559 | N | N | N | Floxuridine
 | DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) | 0.44444 | Fluorouracil
 | 0.015267 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 561 | N | N | N | Tilmacoxib
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.39286 | Ethoxzolamide
 | 0.022842 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 562 | N | N | N | Acetaminophen
| RRM2: ribonucleotide reductase M2 (EC:1.17.4.1) | 0.063830 | Deferoxamine
| 0.030384 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 563 | N | N | N | Salicylic acid
| ACAT1: acetyl-CoA acetyltransferase 1 (EC:2.3.1.9) | 0.31034 | Sulfasalazine
| 0.018560 | LTA4H |
| 565 | N | N | N | Simvastatin
 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.17778 | Bisoprolol
| 0.13075 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 566 | Y | N | N | Zileuton
| LTA4H | 0.40000 | Ketoprofen
| 0.013786 | ALOX5: arachidonate 5-lipoxygenase (EC:1.13.11.34) |
| 567 | N | Y | N | Fludarabine phosphate
| DCK: deoxycytidine kinase (EC:2.7.1.74) | 0.40000 | Gemcitabine
| 0.019062 | RRM1: ribonucleotide reductase M1 (EC:1.17.4.1) |
| 572 | N | N | N | Deferoxamine
| GPX4: glutathione peroxidase 4 (phospholipid hydroperoxidase) (EC:1.11.1.12) | 0.035088 | Diethylstilbestrol
| 0.046704 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 574 | N | N | N | Fludarabine phosphate
| CMPK1: cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (EC:2.7.4.14) | 0.40000 | Gemcitabine
| 0.017727 | POLA1: polymerase (DNA directed), alpha 1, catalytic subunit (EC:2.7.7.7) |
| 577 | N | N | N | Deferoxamine
| GPX7: glutathione peroxidase 7 (EC:1.11.1.9) | 0.035088 | Diethylstilbestrol
| 0.043148 | FECH: ferrochelatase (EC:4.99.1.1) |
| 579 | N | N | N | Atazanavir sulfate
 | REN: renin (EC:3.4.23.15) | 0.44706 | Ditekiren
 | 0.021371 | UGT1A10: UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
| 580 | N | N | N | Fasudil hydrochloride
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.41935 | Clozapine
| 0.027294 | MAPK12: mitogen-activated protein kinase 12 (EC:2.7.11.24) |
| 582 | N | N | N | Vesnarinone
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.48571 | Clozapine
| 0.029363 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 590 | N | N | N | Orlistat
| MGLL: monoglyceride lipase (EC:3.1.1.23) | 0.20000 | Capecitabine
| 0.040662 | LIPA: lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
| 599 | N | N | N | Fluorometholone
| CYP19A1: cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | 0.48485 | Testolactone
| 0.014633 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) |
| 603 | N | N | N | Biotin
| TARS: threonyl-tRNA synthetase (EC:6.1.1.3) | 0.14286 | Threonine
 | 0.014573 | HLCS: holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) (EC:6.3.4.10 6.3.4.11 6.3.4.15 6.3.4.9) |
| 604 | N | N | N | Naproxen
| PTGIS: prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4) | 0.41667 | Metyrapone
| 0.018722 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 605 | N | N | N | Physostigmine salicylate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.44186 | Benazepril hydrochloride
 | 0.011580 | ACHE: acetylcholinesterase (EC:3.1.1.7) |
| 606 | N | N | N | Levetiracetam
| ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.36842 | Captopril
 | 0.013775 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 608 | N | N | N | Pentostatin
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.44000 | Idoxuridine
 | 0.018897 | ADA |
| 612 | N | N | N | Gabapentin
 | BCKDK | 0.25000 | Valine
| 0.020644 | PSAT1: phosphoserine aminotransferase 1 (EC:2.6.1.52) |
| 613 | N | N | N | Celgosivir hydrochloride
| ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.33333 | Capecitabine
| 0.012269 | GAA: glucosidase, alpha; acid (EC:3.2.1.20) |
| 614 | N | N | N | Verapamil
| CA4: carbonic anhydrase IV (EC:4.2.1.1) | 0.22917 | Benzthiazide
| 0.19740 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 615 | N | N | N | Ciclopirox olamine
 | LTA4H | 0.22500 | Ketotifen fumarate
| 0.019303 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 618 | N | N | N | Orlistat
| PAFAH2: platelet-activating factor acetylhydrolase 2, 40kDa (EC:3.1.1.47) | 0.20000 | Capecitabine
| 0.025315 | LIPA: lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
| 620 | N | N | N | Ketotifen fumarate
| PDE9A: phosphodiesterase 9A (EC:3.1.4.35) | 0.37209 | Vesnarinone
| 0.16421 | PDE7A: phosphodiesterase 7A (EC:3.1.4.17) |
| 622 | N | N | N | Napsagatran
| ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.37037 | Delapril hydrochloride
 | 0.010996 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) |
| 623 | N | N | N | Acetohexamide
 | AKR1C1: aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) (EC:1.3.1.20 1.1.1.149 1.1.1.112) | 0.33333 | Haloperidol
| 0.023746 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 625 | N | N | N | Oxiconazole nitrate
| AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.43590 | Zenarestat
 | 0.024614 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 629 | N | N | N | Orlistat
| TYMP: thymidine phosphorylase (EC:2.4.2.4) | 0.20000 | Capecitabine
| 0.020500 | PNPLA3: patatin-like phospholipase domain containing 3 (EC:3.1.1.3) |
| 630 | N | N | N | Amlexanox
 | DHFR: dihydrofolate reductase (EC:1.5.1.3) | 0.43333 | Trimethoprim
 | 0.023456 | EXTL2: exostoses (multiple)-like 2 (EC:2.4.1.223) |
| 631 | N | N | N | Orlistat
| PLA2G12A: phospholipase A2, group XIIA (EC:3.1.1.4) | 0.20000 | Capecitabine
| 0.037930 | PNLIPRP2: pancreatic lipase-related protein 2 (EC:3.1.1.3 3.1.1.26) |
| 632 | N | N | N | Allopurinol
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.30000 | Acyclovir
| 0.010657 | XDH: xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
| 633 | N | N | N | Orlistat
| PLA2G6: phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4) | 0.20000 | Capecitabine
| 0.020117 | PNPLA3: patatin-like phospholipase domain containing 3 (EC:3.1.1.3) |
| 635 | N | N | N | Citric acid, anhydrous
 | PDE9A: phosphodiesterase 9A (EC:3.1.4.35) | 0.28261 | Sildenafil citrate
 | 0.10579 | PDE5A: phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) |
| 636 | N | N | N | Orlistat
| LIPE: lipase, hormone-sensitive (EC:3.1.1.79) | 0.20000 | Capecitabine
| 0.017504 | CEL: carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3) |
| 638 | N | N | N | Sirolimus
 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.35454 | Flunisolide
 | 0.026005 | FKBP1A: FK506 binding protein 1A, 12kDa (EC:5.2.1.8) |
| 640 | N | N | N | Acetohexamide
| AKR1B10: aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) | 0.33333 | Haloperidol
| 0.022981 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 643 | N | N | N | Topotecan hydrochloride
 | TOP2B: topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3) | 0.33962 | Daunorubicin hydrochloride
 | 0.016108 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 644 | N | N | N | Orlistat
| AOAH | 0.20000 | Capecitabine
| 0.020476 | LIPA: lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
| 646 | N | N | N | Indomethacin
 | PTGIS: prostaglandin I2 (prostacyclin) synthase (EC:5.3.99.4) | 0.42424 | Alprazolam
 | 0.018722 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 648 | N | N | N | Threonine
| MCCC2: methylcrotonoyl-CoA carboxylase 2 (beta) (EC:6.4.1.4) | 0.14286 | Biotin
| 0.22230 | PCCB: propionyl CoA carboxylase, beta polypeptide (EC:6.4.1.3) |
| 652 | N | N | N | Orlistat
| BPHL: biphenyl hydrolase-like (serine hydrolase) | 0.20000 | Capecitabine
| 0.028812 | LIPA: lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
| 657 | N | N | N | Topotecan hydrochloride
| TOP2A: topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | 0.33962 | Daunorubicin hydrochloride
| 0.015780 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 659 | N | N | N | Efegatran sulfate
| REN: renin (EC:3.4.23.15) | 0.37705 | Zankiren hydrochloride
 | 0.015677 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) |
| 660 | N | Y | N | Donepezil hydrochloride
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.48780 | Cisapride
| 0.012623 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 663 | N | N | N | Carbamazepine
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.29412 | Benzthiazide
| 0.022337 | CYP2C8: cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
| 669 | N | Y | N | Fluvastatin sodium
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.39474 | Trimipramine
| 0.014302 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
| 670 | N | N | N | Epalrestat
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.38461 | Temocapril hydrochloride
 | 0.014328 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
| 671 | N | N | N | Diethylstilbestrol
| RRM2: ribonucleotide reductase M2 (EC:1.17.4.1) | 0.035088 | Deferoxamine
| 0.032800 | GPX2: glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
| 672 | N | N | N | Propylthiouracil
| SULT1A2: sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 (EC:2.8.2.1) | 0.22222 | Acetaminophen
| 0.023458 | DIO3: deiodinase, iodothyronine, type III (EC:1.97.1.11) |
| 674 | N | N | N | Adenosine
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.44000 | Idoxuridine
| 0.013020 | ADCY1: adenylate cyclase 1 (brain) (EC:4.6.1.1) |
| 675 | N | N | N | Orlistat
| H6PD: hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (EC:1.1.1.47 3.1.1.31) | 0.20000 | Capecitabine
| 0.017406 | LIPC: lipase, hepatic (EC:3.1.1.3) |
| 679 | N | N | N | Gulutamine
 | PCCA | 0.46154 | Isoleucine
| 0.099854 | ACACA: acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
| 680 | N | N | N | Diethylstilbestrol
| CYP2E1: cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.14.1) | 0.40000 | Letrozole
| 0.034476 | GPX2: glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
| 682 | N | Y | N | Eletriptan hydrobromide
 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | 0.41667 | Clozapine
| 0.14153 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 683 | N | N | N | Ethoxzolamide
| ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.38461 | Methyclothiazide
| 0.013918 | CA1: carbonic anhydrase I (EC:4.2.1.1) |
| 684 | N | N | N | Diethylstilbestrol
| CYP1A1: cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | 0.40000 | Letrozole
| 0.029947 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 685 | N | N | N | Orlistat
| CLC: Charcot-Leyden crystal protein (EC:3.1.1.5) | 0.20000 | Capecitabine
| 0.026761 | PNLIPRP2: pancreatic lipase-related protein 2 (EC:3.1.1.3 3.1.1.26) |
| 687 | N | N | N | Milrinone
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.36000 | Fadrozole hydrochloride
| 0.028814 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 688 | N | N | N | Orlistat
| PLA2G3: phospholipase A2, group III (EC:3.1.1.4) | 0.20000 | Capecitabine
| 0.018132 | PNPLA3: patatin-like phospholipase domain containing 3 (EC:3.1.1.3) |
| 689 | N | N | N | Acetohexamide
| ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.38889 | Alacepril
| 0.012963 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 693 | Y | N | N | Zileuton
| PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | 0.47826 | Tiaprofenic acid
| 0.011221 | ALOX5: arachidonate 5-lipoxygenase (EC:1.13.11.34) |
| 694 | N | N | N | Nadide
 | FDXR: ferredoxin reductase (EC:1.18.1.2) | 0.49266 | Flavin adenine dinucleotide
 | 0.031424 | NMNAT3: nicotinamide nucleotide adenylyltransferase 3 (EC:2.7.7.1 2.7.7.18) |
| 695 | Y | Y | N | Tacrolimus
| FKBP1A: FK506 binding protein 1A, 12kDa (EC:5.2.1.8) | 0.49096 | Sirolimus
| 0.055658 | PPIB: peptidylprolyl isomerase B (cyclophilin B) (EC:5.2.1.8) |
| 699 | N | N | N | Uracil
 | GLUD1: glutamate dehydrogenase 1 (EC:1.4.1.3) | 0.083333 | Nadide
| 0.014853 | DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
| 701 | N | N | N | Mofegiline hydrochloride
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.32258 | Haloperidol
| 0.021730 | MAOA |
| 707 | N | N | N | Isoflurophate
| CEL: carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3) | 0.12195 | Orlistat
| 0.20493 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 711 | N | N | N | Deracoxib
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.45946 | Bendroflumethiazide
 | 0.022842 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 712 | N | N | N | Tipifarnib
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.48077 | Liarozole hydrochloride
| 0.019603 | FNTA: farnesyltransferase, CAAX box, alpha (EC:2.5.1.59 2.5.1.58) |
| 713 | N | N | N | Ximelagatran
 | REN: renin (EC:3.4.23.15) | 0.45283 | Terlakiren
| 0.015677 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) |
| 714 | N | N | N | Orlistat
| PGLS: 6-phosphogluconolactonase (EC:3.1.1.31) | 0.20000 | Capecitabine
| 0.024573 | PNPLA3: patatin-like phospholipase domain containing 3 (EC:3.1.1.3) |
| 719 | N | N | N | Oxcarbazepine
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.41176 | Benazeprilat
 | 0.010985 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 720 | N | N | N | Glimepiride
| REN: renin (EC:3.4.23.15) | 0.40000 | Terlakiren
| 0.016019 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 722 | N | N | N | Proline
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.46667 | Captopril
| 0.013158 | PRODH: proline dehydrogenase (oxidase) 1 (EC:1.5.99.8) |
| 724 | N | N | N | Aminoglutethimide
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.44444 | Risarestat
| 0.029508 | CYP4F2: cytochrome P450, family 4, subfamily F, polypeptide 2 (EC:1.14.13.30) |
| 726 | N | N | N | Glimepiride
| F2: coagulation factor II (thrombin) (EC:3.4.21.5) | 0.44681 | Ximelagatran
| 0.014521 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 728 | N | N | N | Ergocalciferol
 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.32558 | Dalvastatin
 | 0.011624 | CYP27B1: cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) |
| 730 | N | N | N | Rivastigmine tartrate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.36956 | Enalapril maleate
 | 0.011580 | ACHE: acetylcholinesterase (EC:3.1.1.7) |
| 731 | N | Y | N | Leflunomide
 | CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.45454 | Phenacetin
| 0.018763 | DHODH: dihydroorotate dehydrogenase (EC:1.3.5.2) |
| 732 | N | N | N | Etazolate hydrochloride
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.39286 | Neostigmine bromide
| 0.034003 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 734 | N | N | N | Fludarabine phosphate
| TYMS: thymidylate synthetase (EC:2.1.1.45) | 0.40000 | Gemcitabine
| 0.013909 | RRM1: ribonucleotide reductase M1 (EC:1.17.4.1) |
| 736 | N | N | N | Biotin
| BCAT1: branched chain amino-acid transaminase 1, cytosolic (EC:2.6.1.42) | 0.27273 | Gabapentin
| 0.020930 | PCCA |
| 739 | N | N | N | Ditekiren
| HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.26584 | Atorvastatin calcium
 | 0.012824 | REN: renin (EC:3.4.23.15) |
| 740 | N | N | N | Imatinib mesilate
| IKBKE: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon (EC:2.7.11.10) | 0.34615 | Sulfasalazine
| 0.088066 | MAP2K1: mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
| 742 | N | N | N | Phytonadione
| F9: coagulation factor IX (EC:3.4.21.22) | 0.35294 | Menadione
| 0.012080 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 743 | N | Y | N | Atazanavir sulfate
| CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.45714 | Lopinavir
| 0.020804 | UGT2A3: UDP glucuronosyltransferase 2 family, polypeptide A3 (EC:2.4.1.17) |
| 746 | N | N | N | Phytonadione
| F7 | 0.35294 | Menadione
| 0.011633 | GGCX: gamma-glutamyl carboxylase (EC:4.1.1.90) |
| 751 | N | N | N | Bentiromide
| ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.39535 | Quinaprilat
 | 0.016518 | CTRC: chymotrypsin C (caldecrin) (EC:3.4.21.2) |
| 753 | N | N | N | Natamycin
 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.28659 | Flunisolide
| 0.014912 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 756 | N | N | N | Amlexanox
| AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.43750 | Ponalrestat
 | 0.019822 | EXTL2: exostoses (multiple)-like 2 (EC:2.4.1.223) |
| 760 | N | N | N | Itopride hydrochloride
 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) | 0.48571 | Dibucaine
 | 0.015532 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 762 | N | N | N | Dalvastatin
| ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.35135 | Galantamine hydrobromide
 | 0.012045 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
| 766 | N | N | N | Methotrexate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.43182 | Quinaprilat
| 0.019584 | DHFR: dihydrofolate reductase (EC:1.5.1.3) |
| 767 | N | N | N | Omeprazole
 | DHFR: dihydrofolate reductase (EC:1.5.1.3) | 0.45714 | Trimetrexate
 | 0.015653 | ATP4A: ATPase, H+/K+ exchanging, alpha polypeptide (EC:3.6.3.10) |
| 770 | N | N | N | Tilmacoxib
| CA2: carbonic anhydrase II (EC:4.2.1.1) | 0.38710 | Methyclothiazide
| 0.018944 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 771 | N | N | N | Natamycin
| ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.10345 | Idoxuridine
| 0.015455 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 774 | N | N | N | Medrysone
| CYP19A1: cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | 0.46875 | Testolactone
| 0.014633 | PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) |
| 775 | N | N | N | Nepicastat hydrochloride
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.36111 | Lidorestat
 | 0.025245 | DBH: dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) |
| 776 | N | N | N | Bisoprolol
| HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.46154 | Cerivastatin sodium
 | 0.011980 | CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
| 779 | N | N | N | Minalrestat
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.41176 | Diazepam
| 0.020573 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
| 781 | N | N | N | Floxuridine
| TK2: thymidine kinase 2, mitochondrial (EC:2.7.1.21) | 0.44444 | Fluorouracil
| 0.025147 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 782 | N | N | N | Deferoxamine
| WARS: tryptophanyl-tRNA synthetase (EC:6.1.1.2) | 0.041667 | Propylthiouracil
| 0.027023 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 783 | N | N | N | Mycophenolate mofetil
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.33333 | Donepezil hydrochloride
| 0.015455 | IMPDH1: IMP (inosine 5'-monophosphate) dehydrogenase 1 (EC:1.1.1.205) |
| 784 | N | N | N | Zileuton
| CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.39130 | Ethoxzolamide
| 0.020347 | ALOX5: arachidonate 5-lipoxygenase (EC:1.13.11.34) |
| 785 | N | N | N | Salicylic acid
| PRDX3: peroxiredoxin 3 (EC:1.11.1.15) | 0.31250 | Acetaminophen
| 0.022175 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
| 788 | N | N | N | Threonine
| PC: pyruvate carboxylase (EC:6.4.1.1) | 0.14286 | Biotin
| 0.21172 | PCCA |
| 789 | N | N | N | Nalidixic acid
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.37500 | Acyclovir
| 0.013773 | TOP2B: topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3) |
| 792 | N | N | N | Deferoxamine
| GPX2: glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) | 0.035088 | Diethylstilbestrol
| 0.035543 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 793 | N | N | N | Zaleplon
| CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | 0.42857 | Metyrapone
| 0.012339 | ACOX1: acyl-CoA oxidase 1, palmitoyl (EC:1.3.3.6) |
| 797 | N | N | N | Flavin adenine dinucleotide
| ADCY1: adenylate cyclase 1 (brain) (EC:4.6.1.1) | 0.49266 | Nadide
| 0.019744 | ACADS: acyl-CoA dehydrogenase, C-2 to C-3 short chain (EC:1.3.99.2) |
| 798 | N | N | N | Valacyclovir hydrochloride
 | DHFR: dihydrofolate reductase (EC:1.5.1.3) | 0.32353 | Trimethoprim
| 0.024139 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) |
| 799 | N | N | N | Icopezil maleate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.44444 | Benazeprilat
| 0.011580 | ACHE: acetylcholinesterase (EC:3.1.1.7) |
| 803 | N | N | N | Gulutamine
| PCCB: propionyl CoA carboxylase, beta polypeptide (EC:6.4.1.3) | 0.46154 | Isoleucine
| 0.038514 | ACACA: acetyl-CoA carboxylase alpha (EC:6.4.1.2 6.3.4.14) |
| 806 | N | N | N | Cilomilast
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.36585 | Cilazapril
 | 0.016550 | PDE6H: phosphodiesterase 6H, cGMP-specific, cone, gamma (EC:3.1.4.35) |
| 807 | N | N | N | Fluorouracil
| ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.44444 | Idoxuridine
| 0.023384 | DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
| 808 | N | N | N | Demecarium bromide
 | CEL: carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3) | 0.26230 | Orlistat
| 0.20493 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 809 | Y | N | N | Metoclopramide
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.42424 | Itopride hydrochloride
| 0.013404 | TRIM32: tripartite motif containing 32 |
| 810 | N | N | N | Eletriptan hydrobromide
| CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.41026 | Bendroflumethiazide
| 0.019360 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 812 | N | N | N | Salicylic acid
| PRDX4: peroxiredoxin 4 (EC:1.11.1.15) | 0.31250 | Acetaminophen
| 0.026876 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
| 813 | N | N | N | Capecitabine
| CMPK1: cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (EC:2.7.4.14) | 0.43333 | Gemcitabine
| 0.052896 | PLA2G10: phospholipase A2, group X (EC:3.1.1.4) |
| 816 | N | N | N | Deferoxamine
| GPX1: glutathione peroxidase 1 (EC:1.11.1.9) | 0.035088 | Diethylstilbestrol
| 0.039142 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 819 | N | N | N | Benazeprilat
| AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.43243 | Ponalrestat
| 0.014328 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) |
| 821 | N | N | N | Deferoxamine
| REN: renin (EC:3.4.23.15) | 0.21875 | Aliskiren
 | 0.025435 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 822 | N | N | N | Topiramate
| PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.26190 | Flurandrenolide
 | 0.018276 | CA2: carbonic anhydrase II (EC:4.2.1.1) |
| 823 | N | N | N | Tranexamic acid
 | F12: coagulation factor XII (Hageman factor) (EC:3.4.21.38) | 0.33333 | Aminocaproic acid
| 0.24070 | PLAU: plasminogen activator, urokinase (EC:3.4.21.73) |
| 826 | N | N | N | Deferoxamine
| GPX3: glutathione peroxidase 3 (plasma) (EC:1.11.1.9) | 0.035088 | Diethylstilbestrol
| 0.038088 | PRDX1: peroxiredoxin 1 (EC:1.11.1.15) |
| 827 | N | N | N | Testolactone
| HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.37838 | Lovastatin
 | 0.013159 | CYP19A1: cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
| 828 | N | N | N | Milrinone
| CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.36000 | Fadrozole hydrochloride
| 0.031325 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 830 | N | N | N | Uracil
| WARS: tryptophanyl-tRNA synthetase (EC:6.1.1.2) | 0.46154 | Propylthiouracil
| 0.012027 | DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
| 831 | N | N | N | Orlistat
| AADAC: arylacetamide deacetylase (esterase) (EC:3.1.1.3) | 0.20000 | Capecitabine
| 0.040389 | CEL: carboxyl ester lipase (bile salt-stimulated lipase) (EC:3.1.1.13 3.1.1.3) |
| 832 | N | N | N | Docebenone
 | LTA4H | 0.17500 | Phenylbutazone
 | 0.013786 | ALOX5: arachidonate 5-lipoxygenase (EC:1.13.11.34) |
| 833 | N | N | N | Digoxin
| PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.31848 | Flunisolide
| 0.011338 | ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) |
| 837 | N | N | N | Felbamate
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.32258 | Pentopril
 | 0.010985 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 841 | N | N | N | Orlistat
| ESD: esterase D (EC:3.1.2.12) | 0.20000 | Capecitabine
| 0.042052 | PNLIP: pancreatic lipase (EC:3.1.1.3 3.1.1.21) |
| 843 | N | N | N | Amphotericin B
 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.078947 | Idoxuridine
| 0.015455 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 845 | N | N | N | Methoxsalen
 | HSD11B1: hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146) | 0.32000 | Metyrapone
| 0.027887 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 846 | N | N | N | Metyrapone
| DHRS4: dehydrogenase/reductase (SDR family) member 4 (EC:1.1.1.184) | 0.20000 | Menadione
| 0.22812 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 847 | N | N | N | Floxuridine
| UMPS: uridine monophosphate synthetase (EC:2.4.2.10 4.1.1.23) | 0.44444 | Fluorouracil
| 0.017797 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 849 | N | N | N | Adenosine phosphate
| NT5C2: 5'-nucleotidase, cytosolic II (EC:3.1.3.5) | 0.48148 | Ribavirin
 | 0.027486 | APRT: adenine phosphoribosyltransferase (EC:2.4.2.7) |
| 850 | N | N | N | Tilmacoxib
| CA4: carbonic anhydrase IV (EC:4.2.1.1) | 0.38710 | Methyclothiazide
| 0.018312 | PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 852 | N | N | N | Peramivir
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.36842 | Perindopril
 | 0.013549 | NEU2: sialidase 2 (cytosolic sialidase) (EC:3.2.1.18) |
| 853 | N | N | N | Irinotecan hydrochloride
 | TOP2B: topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3) | 0.29578 | Pirarubicin
 | 0.016108 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 855 | N | N | N | Dichlorphenamide
 | DHFR: dihydrofolate reductase (EC:1.5.1.3) | 0.30769 | Chloroguanide hydrochloride
 | 0.037935 | CA7: carbonic anhydrase VII (EC:4.2.1.1) |
| 856 | N | N | N | Diazoxide
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.47059 | Chlorzoxazone
| 0.023687 | CA4: carbonic anhydrase IV (EC:4.2.1.1) |
| 859 | N | N | N | Rasagiline mesylate
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.39130 | Zonisamide
 | 0.021288 | MAOB: monoamine oxidase B (EC:1.4.3.4) |
| 860 | N | N | N | Floxuridine
| TK1: thymidine kinase 1, soluble (EC:2.7.1.21) | 0.44444 | Fluorouracil
| 0.020371 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 861 | N | N | N | Methimazole
| PRDX5: peroxiredoxin 5 (EC:1.11.1.15) | 0.23077 | Benzoic acid
 | 0.036495 | DIO2: deiodinase, iodothyronine, type II (EC:1.97.1.10) |
| 863 | N | N | N | Nadide
| GCDH: glutaryl-CoA dehydrogenase (EC:1.3.99.7) | 0.49266 | Flavin adenine dinucleotide
| 0.026792 | HSD17B1: hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) |
| 865 | N | N | N | Orotic acid
 | TYMS: thymidylate synthetase (EC:2.1.1.45) | 0.42857 | Fluorouracil
| 0.022878 | DHODH: dihydroorotate dehydrogenase (EC:1.3.5.2) |
| 868 | N | N | N | Irinotecan hydrochloride
| TOP2A: topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | 0.29578 | Pirarubicin
| 0.015780 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 870 | N | N | N | Floxuridine
| UPP2: uridine phosphorylase 2 (EC:2.4.2.3) | 0.44444 | Fluorouracil
| 0.019017 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 871 | N | N | N | Tipifarnib
| CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | 0.48077 | Liarozole hydrochloride
| 0.022891 | FNTA: farnesyltransferase, CAAX box, alpha (EC:2.5.1.59 2.5.1.58) |
| 876 | N | N | N | Libenzapril
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.37143 | Risarestat
| 0.014328 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) |
| 885 | N | N | N | Salicylic acid
| PRDX1: peroxiredoxin 1 (EC:1.11.1.15) | 0.31250 | Acetaminophen
| 0.027451 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
| 886 | N | N | N | Leucovorin calcium
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.37500 | Lisinopril
 | 0.011056 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 888 | N | N | N | Tretinoin
 | ALDH7A1: aldehyde dehydrogenase 7 family, member A1 (EC:1.2.1.3 1.2.1.8 1.2.1.31) | 0.15152 | Disulfiram
| 0.22151 | ALDH1A2: aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36) |
| 889 | N | N | N | Acarbose
 | ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.36651 | Deslanoside
 | 0.011908 | AMY2A: amylase, alpha 2A (pancreatic) (EC:3.2.1.1) |
| 890 | N | N | N | Floxuridine
| UPP1: uridine phosphorylase 1 (EC:2.4.2.3) | 0.44444 | Fluorouracil
| 0.017560 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 891 | N | N | N | Terbinafine
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.37931 | Rivastigmine
 | 0.013938 | SQLE: squalene epoxidase (EC:1.14.99.7) |
| 892 | N | N | N | Lovastatin
| PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.36170 | Fluocinonide
 | 0.0098159 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
| 893 | N | N | N | Indomethacin
| PDE7A: phosphodiesterase 7A (EC:3.1.4.17) | 0.38889 | Pimobendan
 | 0.018778 | ALOX15: arachidonate 15-lipoxygenase (EC:1.13.11.33) |
| 894 | N | N | N | Pantoprazole
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.37209 | Verapamil
| 0.021147 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 895 | N | N | N | Haloperidol
| HSD11B1: hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146) | 0.30303 | Metyrapone
| 0.10272 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 898 | N | N | N | Exatecan mesylate
 | TOP2B: topoisomerase (DNA) II beta 180kDa (EC:5.99.1.3) | 0.30000 | Daunorubicin hydrochloride
| 0.016108 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 899 | N | N | N | Celgosivir hydrochloride
| HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.37143 | Lovastatin
| 0.012311 | GAA: glucosidase, alpha; acid (EC:3.2.1.20) |
| 901 | N | N | N | Methoxsalen
| HSD11B2: hydroxysteroid (11-beta) dehydrogenase 2 (EC:1.1.1.146) | 0.32000 | Metyrapone
| 0.029233 | CH25H: cholesterol 25-hydroxylase (EC:1.14.99.38) |
| 903 | N | N | N | Nadide
| DAO: D-amino-acid oxidase (EC:1.4.3.3) | 0.49266 | Flavin adenine dinucleotide
| 0.031685 | GAPDH: glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
| 905 | N | N | N | Nadide
| XDH: xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) | 0.49266 | Flavin adenine dinucleotide
| 0.020050 | HSD17B1: hydroxysteroid (17-beta) dehydrogenase 1 (EC:1.1.1.62) |
| 906 | N | N | N | Benzoic acid
| PRDX1: peroxiredoxin 1 (EC:1.11.1.15) | 0.33333 | Acetaminophen
| 0.095456 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 907 | N | N | N | Orotic acid
| ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.27273 | Idoxuridine
| 0.021396 | DHODH: dihydroorotate dehydrogenase (EC:1.3.5.2) |
| 908 | N | N | N | Esomeprazole magnesium
 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.35227 | Rosuvastatin calcium
 | 0.0093394 | ATP4A: ATPase, H+/K+ exchanging, alpha polypeptide (EC:3.6.3.10) |
| 909 | N | N | N | Exatecan mesylate
| TOP2A: topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | 0.30000 | Daunorubicin hydrochloride
| 0.015780 | TOP1: topoisomerase (DNA) I (EC:5.99.1.2) |
| 910 | N | N | N | Acetohexamide
| AKR1A1: aldo-keto reductase family 1, member A1 (aldehyde reductase) (EC:1.1.1.2) | 0.33333 | Haloperidol
| 0.022436 | DCXR: dicarbonyl/L-xylulose reductase (EC:1.1.1.10) |
| 911 | N | N | N | Raltitrexed
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.40000 | Ponalrestat
| 0.021810 | TYMS: thymidylate synthetase (EC:2.1.1.45) |
| 916 | N | N | N | Selegiline hydrochloride
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.47368 | Edrophonium chloride
| 0.013318 | MAOA |
| 917 | N | N | N | Flavin adenine dinucleotide
| BLVRB: biliverdin reductase B (flavin reductase (NADPH)) (EC:1.3.1.24 1.5.1.30) | 0.48148 | Riboflavin
| 0.040923 | DAO: D-amino-acid oxidase (EC:1.4.3.3) |
| 918 | N | N | N | Fluorouracil
| DCK: deoxycytidine kinase (EC:2.7.1.74) | 0.22727 | Gemcitabine
| 0.23118 | TK2: thymidine kinase 2, mitochondrial (EC:2.7.1.21) |
| 919 | N | N | N | Profenamine hydrochloride
 | ACE: angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) | 0.44737 | Benazepril hydrochloride
| 0.013064 | BCHE: butyrylcholinesterase (EC:3.1.1.8) |
| 921 | N | Y | N | Celecoxib
 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) | 0.42105 | Eletriptan hydrobromide
| 0.14915 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 924 | N | N | N | Orlistat
| PAFAH1B3: platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) (EC:3.1.1.47) | 0.20000 | Capecitabine
| 0.025172 | LIPA: lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
| 925 | N | N | N | Tacrine hydrochloride
 | CA1: carbonic anhydrase I (EC:4.2.1.1) | 0.36364 | Diazoxide
| 0.018213 | ACHE: acetylcholinesterase (EC:3.1.1.7) |
| 926 | N | N | N | Flavin adenine dinucleotide
| RFK: riboflavin kinase (EC:2.7.1.26) | 0.48148 | Riboflavin
| 0.036571 | NQO1: NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
| 928 | N | N | N | Sulfasalazine
| MPO | 0.33333 | Diethylstilbestrol
| 0.016875 | NAT2: N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
| 929 | N | N | N | Mycophenolate mofetil
| NT5C2: 5'-nucleotidase, cytosolic II (EC:3.1.3.5) | 0.24390 | Pentoxifylline
| 0.014870 | IMPDH1: IMP (inosine 5'-monophosphate) dehydrogenase 1 (EC:1.1.1.205) |
| 930 | N | N | N | Benzoic acid
| PRDX3: peroxiredoxin 3 (EC:1.11.1.15) | 0.33333 | Acetaminophen
| 0.091240 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 931 | N | N | N | Capecitabine
| DCK: deoxycytidine kinase (EC:2.7.1.74) | 0.43333 | Gemcitabine
| 0.034332 | PLA2G2D: phospholipase A2, group IID (EC:3.1.1.4) |
| 932 | N | N | N | Riboflavin
| DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) | 0.48148 | Flavin adenine dinucleotide
| 0.019245 | RFK: riboflavin kinase (EC:2.7.1.26) |
| 933 | N | N | N | Cholecalciferol
 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.32558 | Lovastatin
| 0.014868 | CYP27A1: cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
| 935 | N | N | N | Capecitabine
| ZMPSTE24: zinc metallopeptidase (STE24 homolog, S. cerevisiae) (EC:3.4.24.84) | 0.32258 | Clofibrate
 | 0.026416 | PLA2G10: phospholipase A2, group X (EC:3.1.1.4) |
| 936 | N | N | N | Orlistat
| PAFAH1B2 | 0.20000 | Capecitabine
| 0.024619 | PNLIP: pancreatic lipase (EC:3.1.1.3 3.1.1.21) |
| 939 | N | N | N | Gabapentin
| ACADSB: acyl-CoA dehydrogenase, short/branched chain (EC:1.3.99.-) | 0.23529 | Isoleucine
| 0.045302 | ACOX1: acyl-CoA oxidase 1, palmitoyl (EC:1.3.3.6) |
| 940 | N | N | N | Choline salicylate
 | CRAT: carnitine O-acetyltransferase (EC:2.3.1.7) | 0.47368 | Levocarnitine
 | 0.016847 | PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 941 | N | N | N | Nadide
| ACADS: acyl-CoA dehydrogenase, C-2 to C-3 short chain (EC:1.3.99.2) | 0.49266 | Flavin adenine dinucleotide
| 0.036975 | HSD17B10: hydroxysteroid (17-beta) dehydrogenase 10 (EC:1.1.1.35 1.1.1.178) |
| 943 | N | N | N | Razaxaban hydrochloride
 | F2: coagulation factor II (thrombin) (EC:3.4.21.5) | 0.33333 | Chlorpromazine
 | 0.19139 | F10: coagulation factor X (EC:3.4.21.6) |
| 944 | N | N | N | Uracil
| TPO: thyroid peroxidase (EC:1.11.1.8) | 0.46154 | Propylthiouracil
| 0.010795 | DPYD: dihydropyrimidine dehydrogenase (EC:1.3.1.2) |
| 947 | N | N | N | Mitomycin
| PLA2G4A: phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) | 0.28261 | Fluocinonide
| 0.016808 | NQO1: NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
| 950 | N | N | N | Benzoic acid
| PRDX4: peroxiredoxin 4 (EC:1.11.1.15) | 0.33333 | Acetaminophen
| 0.088898 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 952 | N | N | N | Choline salicylate
| CROT: carnitine O-octanoyltransferase (EC:2.3.1.137) | 0.47368 | Levocarnitine
| 0.015552 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 953 | N | N | N | Fluvastatin sodium
| CYP2D6: cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | 0.39474 | Trimipramine
| 0.011980 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
| 955 | N | N | N | Nadide
| IVD: isovaleryl-CoA dehydrogenase (EC:1.3.99.10) | 0.49266 | Flavin adenine dinucleotide
| 0.031928 | ADH7: alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (EC:1.1.1.1) |
| 956 | N | N | N | Adenosine phosphate
| IMPDH1: IMP (inosine 5'-monophosphate) dehydrogenase 1 (EC:1.1.1.205) | 0.48148 | Ribavirin
| 0.021964 | APRT: adenine phosphoribosyltransferase (EC:2.4.2.7) |
| 957 | N | N | N | Imatinib mesilate
| CHUK: conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) | 0.34615 | Sulfasalazine
| 0.074714 | MAP2K1: mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
| 958 | N | Y | N | Ketotifen fumarate
| PDE4B: phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) | 0.37209 | Vesnarinone
| 0.21860 | PDE7A: phosphodiesterase 7A (EC:3.1.4.17) |
| 959 | N | N | N | Tolrestat
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.34210 | Itopride hydrochloride
| 0.020508 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
| 960 | N | N | N | Propylthiouracil
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.27273 | Aminoglutethimide
| 0.023342 | DIO1: deiodinase, iodothyronine, type I (EC:1.97.1.10) |
| 961 | N | N | N | Choline salicylate
| CPT2: carnitine palmitoyltransferase 2 (EC:2.3.1.21) | 0.47368 | Levocarnitine
| 0.020146 | PTGS2: prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 962 | N | N | N | Tipifarnib
| CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) | 0.48077 | Liarozole hydrochloride
| 0.017771 | FNTA: farnesyltransferase, CAAX box, alpha (EC:2.5.1.59 2.5.1.58) |
| 965 | N | N | N | Pentoxifylline
| IMPDH1: IMP (inosine 5'-monophosphate) dehydrogenase 1 (EC:1.1.1.205) | 0.24390 | Mycophenolate mofetil
| 0.025934 | PDE6G: phosphodiesterase 6G, cGMP-specific, rod, gamma (EC:3.1.4.35) |
| 966 | N | N | N | Choline salicylate
| CPT1A: carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) | 0.47368 | Levocarnitine
| 0.016417 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 968 | N | N | N | Sumatriptan
 | MUSK: muscle, skeletal, receptor tyrosine kinase (EC:2.7.10.1) | 0.33333 | Metoclopramide
| 0.011076 | TRIM32: tripartite motif containing 32 |
| 969 | N | N | N | Ketotifen fumarate
| PDE5A: phosphodiesterase 5A, cGMP-specific (EC:3.1.4.35) | 0.37209 | Vesnarinone
| 0.11302 | PDE7B: phosphodiesterase 7B (EC:3.1.4.17) |
| 970 | N | N | N | Triazolam
 | AKR1B1: aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) | 0.44118 | Zenarestat
| 0.020573 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 973 | N | N | N | Calcitriol
 | HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.33333 | Simvastatin
| 0.011624 | CYP27B1: cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) |
| 978 | N | N | N | Diazoxide
| CYP1A1: cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | 0.47059 | Chlorzoxazone
| 0.022252 | CA4: carbonic anhydrase IV (EC:4.2.1.1) |
| 979 | N | N | N | Deferoxamine
| GPX5 | 0.035088 | Diethylstilbestrol
| 0.035631 | PRDX5: peroxiredoxin 5 (EC:1.11.1.15) |
| 980 | N | N | N | Alvocidib hydrochloride
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.44444 | Clozapine
| 0.024135 | CDK1: cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
| 981 | N | N | N | Ketotifen fumarate
| PDE1A: phosphodiesterase 1A, calmodulin-dependent (EC:3.1.4.17) | 0.37209 | Vesnarinone
| 0.17938 | PDE7B: phosphodiesterase 7B (EC:3.1.4.17) |
| 982 | N | N | N | Oseltamivir phosphate
 | ACHE: acetylcholinesterase (EC:3.1.1.7) | 0.23810 | Capecitabine
| 0.021118 | NEU4: sialidase 4 (EC:3.2.1.18) |
| 983 | N | N | N | Tretinoin
| HMGCR: 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | 0.28205 | Dalvastatin
| 0.011195 | ALDH1A2: aldehyde dehydrogenase 1 family, member A2 (EC:1.2.1.36) |
| 986 | N | N | N | Trifluridine
 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) | 0.24138 | Acyclovir
| 0.015455 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) |
| 988 | N | N | N | Ganciclovir
| PNP: purine nucleoside phosphorylase (EC:2.4.2.1) | 0.48000 | Inosine
 | 0.021956 | ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) |
| 989 | N | N | N | Menadione
| PRSS3: protease, serine, 3 (EC:3.4.21.4) | 0.043478 | Isoflurophate
| 0.24890 | F9: coagulation factor IX (EC:3.4.21.22) |
| 990 | N | N | N | Carbamazepine
| AADAC: arylacetamide deacetylase (esterase) (EC:3.1.1.3) | 0.24390 | Verapamil
| 0.021091 | CYP3A4: cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32) |
| 991 | N | N | N | Sulfasalazine
| EPX: eosinophil peroxidase (EC:1.11.1.7) | 0.33333 | Diethylstilbestrol
| 0.017870 | NAT2: N-acetyltransferase 2 (arylamine N-acetyltransferase) (EC:2.3.1.5) |
| 992 | N | N | N | Amphotericin B
| ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide (EC:3.6.3.9) | 0.37147 | Digoxin
| 0.011877 | ABO: ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (EC:2.4.1.37 2.4.1.40) |
| 993 | N | N | N | Felbamate
| DHFR: dihydrofolate reductase (EC:1.5.1.3) | 0.30769 | Pyrimethamine
| 0.025546 | CYP2C19: cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 997 | N | Y | N | Pantoprazole
| CYP1A2: cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | 0.35484 | Methoxsalen
| 0.22792 | CYP2C9: cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
| 998 | N | N | N | Diflunisal
 | IKBKB: inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) | 0.48276 | Sulindac
| 0.012624 | PTGS1: prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
| 1000 | N | N | N | Capecitabine
| ACAA1: acetyl-CoA acyltransferase 1 (EC:2.3.1.16) | 0.44828 | Idoxuridine
| 0.028488 | PLA2G2A: phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |